Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart

Cardiovascular Research

Volumn 63, Issue 4, 2004, Pages 673-681

  Russell, Fraser D ^a   Molenaar, Peter ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Contractile function; Protein kinase C; Signal transduction; Urotensin II

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4ALPHA PHORBOL; CHELERYTHRINE; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE INHIBITOR; PHORBOL 12 ACETATE 13 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE INHIBITOR; RHO KINASE; UROTENSIN II; WORTMANNIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME ACTIVATION; ENZYME ASSAY; FEMALE; HEART FUNCTION; HEART RIGHT ATRIUM; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; INOTROPISM; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ALKALOIDS; AMIDES; ANDROSTADIENES; BENZOPHENANTHRIDINES; ENDOTHELIN-1; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOSIN-LIGHT-CHAIN KINASE; PHENANTHRIDINES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; SIGNAL TRANSDUCTION; STIMULATION, CHEMICAL; TETRADECANOYLPHORBOL ACETATE; UROTENSINS;

EID: 4043056592     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.05.009     Document Type: Article

References (29)

1. Sauzeau V., Mellionnec E.L., Bertoglio J., Scalbert E., Pacaud P., Loirand G. Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ. Res. 88:2001;1102-1104
2. Russell F.D., Molenaar P., O'Brien D. Cardiostimulant effects of urotensin-II in human heart in vitro. Br. J. Pharmacol. 132:2001;5-9
3. 2+ signalling in rabbit ventricular myocytes. Br. J. Pharmacol. 131:2000;638-644
4. 2+- stimulated actomyosin MgATPase activity. Biochem. Biophys. Res. Commun. 193:1993;254-260
5. Venema R.C., Raynor R.L., Noland T.A., Kuo J.F. Role of protein kinase C in the phosphorylation of cardiac myosin light chain 2. Biochem. J. 294:1993;401-406
6. Levine R.J., Kensler R.W., Yang Z., Stull J.T., Sweeney H.L. Myosin light chain phosphorylation affects the structure of rabbit skeletal muscle thick filaments. Biophys. J. 71:1996;898-907
7. Metzger J.M., Greaser M.L., Moss R.L. Variations in cross-bridge attachment rate and tension with phosphorylation of myosin in mammalian skinned skeletal muscle fibers. Implications for twitch potentiation in intact muscle. J. Gen. Physiol. 93:1989;855-883
8. Damron D.S., Darvish A., Murphy L.A., Sweet W., Moravec C.S., Bond M. Arachidonic acid-dependent phosphorylation of troponin I and myosin light chain 2 in cardiac myocytes. Circ. Res. 76:1995;1011-1019
9. Rossmanith G.H., Hoh J.F.Y., Turnbull L., Ludowyke R.I. Mechanism of action of endothelin in rat cardiac muscle: cross-bridge kinetics and myosin light chain phosphorylation. J. Physiol. 505(1):1997;217-227
10. 1-AR-induced positive inotropic response in heart is dependent on myosin light chain phosphorylation. Am. J. Physiol. Heart Circ. Physiol. 283:2002;H1471-H1480
11. 1- adrenergic positive inotropic effect dependes on myosin light chain-2 phosphorylation in human atrium, but not in ventricle. Naunyn Schmiedebergs Arch. Pharmacol. 367:2003;R28. (Abstract)
12. Kawano Y., Fukata Y., Oshiro N., et al. Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J. Cell Biol. 147:1999;1023-1037
13. Wolkowicz P.E., Ku D.D., Grenett H.E., Urthaler F. Occupation of the prostaglandin E2-type 1 receptor increases rat atrial contractility via a Y-27632-sensitive pathway. Prostaglandins Other Lipid Mediat. 70:2002;91-105
14. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275
15. Meyer M., Lehnart S., Pieske B., et al. Influence of endothelin 1 on human atrial myocardium - myocardial function and subcellular pathways. Basic Res. Cardiol. 91:1996;86-93
16. Erdbrügger W., Keffel J., Knocks M., Otto T., Philipp T., Michel M.C. Protein kinase C isoenzymes in rat and human cardiovascular tissues. Br. J. Pharmacol. 120:1997;177-186
17. Rybin V.O., Xu X., Steinberg S.F. Activated protein kinase C isoforms target to cardiomyocyte caveolae. Stimulation of local protein phosphorylation. Circ. Res. 84:1999;980-988
18. 1-adrenoceptor-mediated inotropic responses of neonatal rat hearts. Am. J. Physiol. Heart Circ. Physiol. 273:1997;H1113-H1118
19. + exchanger. Circ. Res. 68:1991;269-279
20. Allen D.G., Orchard C.H. The effects of changes of pH on intracellular calcium transients in mammalian cardiac muscle. J. Physiol. 335:1983;555-567
21. Jideama N.M., Noland T.A., Raynor R.L., et al. Phosphorylation specificities of protein kinase C isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties. J. Biol. Chem. 271:1996;23277-23283
22. Shaw A.S.Y. Slick signalling. Nat. Immunol. 3:2002;1058-1059
23. Newton A.C. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev. 101:2001;2353-2364
24. Parker P.J., Parkinson S.J. AGC protein kinase phosphorylation and protein kinase C. Biochem. Soc. Trans. 29:2001;860-863
25. 1-adrenergic receptor-induced cardiac hypertrophy. Circ. Res. 91:2002;961-969
26. Ishizaki T., Uehata M., Tamechika I., et al. Pharmacological properties of Y-27632, a specific inhibitor of Rho-associated kinases. Mol. Pharmacol. 57:2000;976-983
27. Batchelor T.J.P., Sadaba J.R., Ishola A., Pacaud P., Munsch C.M., Beech D.J. Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery. Br. J. Pharmacol. 132:2001;302-308
28. Uehata M., Ishizaki T., Satoh H., et al. Calcium sensitisation of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 389:1997;990-994
29. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83:2003;1325-1358